Katie Simkow
Gerontology · Livonia, MINPI 1053770305
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.2% of the total across 348 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 20.3% — the pattern of someone who eats at a lot of different presentations. Among gerontology clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 348 payments — averaging $17.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Lilly USA, LLC$868
- AbbVie$866
- Novo Nordisk$583
- Pfizer$563
- GSK$511
- plus $2K from 22 others
What the payments were for
- Food & beverage$5,98497%
- Education$1743%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 52 | $1,252 |
| Lilly USA, LLC | 36 | $868 |
| AbbVie | 67 | $866 |
| Novo Nordisk | 41 | $583 |
| Pfizer | 36 | $563 |
| GSK | 27 | $511 |
| Amgen | 14 | $235 |
| Boehringer Ingelheim | 12 | $226 |
| Astellas Pharma US Inc | 7 | $164 |
| Currax Pharmaceuticals LLC | 15 | $147 |
| Exact Sciences | 6 | $120 |
| Dexcom, Inc. | 5 | $76 |
| Abbott | 3 | $71 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $71 |
| Biohaven Pharmaceuticals, Inc. | 3 | $49 |
| Aimmune Therapeutics, Inc. | 2 | $40 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $40 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $37 |
| Axsome Therapeutics, Inc. | 2 | $37 |
| Endo Pharmaceuticals Inc. | 2 | $32 |
| Merck | 2 | $32 |
| Teva Pharmaceuticals USA, Inc. | 2 | $29 |
| Novartis | 1 | $25 |
| Esperion Therapeutics, Inc. | 1 | $19 |
| Actelion Pharmaceuticals US, Inc. | 1 | $18 |
| Sanofi Pasteur Inc. | 1 | $17 |
| Johnson & Johnson | 1 | $16 |
| Eisai Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,158 in reported general payments places this provider in the 95th percentile of 279 gerontology providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 70 | $99,925 |
| JardianceEmpagliflozin | 77 | $84,960 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 84 | $81,353 |
| EliquisApixaban | 68 | $77,695 |
| MounjaroTirzepatide | 41 | $47,938 |
| TrulicityDulaglutide | 32 | $46,515 |
| FarxigaDapagliflozin Propanediol | 34 | $31,695 |
| JanuviaSitagliptin Phosphate | 24 | $31,118 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 21 | $22,042 |
| TradjentaLinagliptin | 18 | $18,115 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 35 | $6,405 |
| Atorvastatin Calcium | 357 | $4,580 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 32 | $4,076 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 100 | $3,750 |
| SynthroidLevothyroxine Sodium | 38 | $3,157 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Tradjenta | $226 | $103,07695 claims |
| Novo NordiskOzempic | $583 | $99,92570 claims |
| Lilly USA, LLCMounjaro, Trulicity | $868 | $94,45373 claims |
| GSKTrelegy Ellipta | $511 | $81,35384 claims |
| PfizerEliquis | $563 | $77,69568 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $1,252 | $53,73755 claims |
| MerckJanuvia | $32 | $31,11824 claims |
| AbbVieSynthroid | $866 | $3,15738 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 279 gerontology providers in Michigan.
Other gerontology in Livonia
- Micah TroupLivonia$5K
- Alexandrina BerghianLivonia$2K
- Gwendolyn WrightGrand Blanc$47K
- Matthew AmanRochester Hills$21K
- Sarah ArnkoffWest Bloomfield$18K
- Deborah GriffinPetoskey$11K
- Angela EmbreeGrand Rapids$10K
- Bethany DalessandroWyandotte$10K
- Gabrielle NadeauJackson$10K
- Cynthera McNeillWest Bloomfield$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.